Registry FAQs



The Philippine Clinical Trial Registry is a publicly-accessible database containing information on the design, conduct, and administration of clinical trials in the Philippines. The registry also serves as the official platform for registration of clinical trials approved for conduct by the Food and Drug Administration (FDA).
You may access the registry through its official website http://registry.healthresearch.ph.
The registry is publicly-accessible. You may search the registry without creating an account. However, if you want to contribute and register a study, you have to create an account as a researcher.
In the Philippine Clinical Trial Registry homepage, under the section “Search for a Clinical Trial,” field, fill in any of the boxes based on the search term you are interested in. For instance, you may search for On-going studies under the Status box then click Search. If there are additional information that you wish to include, you may use Advanced Search.
All clinical trials approved for conduct by the FDA are required to register their studies in the Philippine Clinical Trial Registry. Other studies that are not regulated by the FDA but have gained approval by an appropriate Ethics Review Committee are encouraged to register their studies.
By virtue of DOH Administrative Order No. 2020-0010, clinical trials approved for conduct by the FDA must be registered within 30 days of receiving approval.
To register a study, one must Sign-up as a Researcher. From the homepage, Log-in to your account. Input your account name and password and click Log-in. Upon successful log-in, the Main Menu will contain an option for Registration.
Please click create an account in the Login page.
If an account holder forgets the password or wants to reset the password, please click on the “Forgot your password” link on the Login page.
The Philippine Clinical Trial Registry is maintained by the Department of Science and Technology in partnership with the Department of Health.
The Philippine Clinical Trial Registry was created to provide readily-available information for researchers, healthcare professionals, patients, and the general public on clinical researches conducted in the Philippines.
A clinical study must be registered by the Sponsor/Contract Research Organization (CRO).
No. Once a study has been registered, it cannot be removed and remains publicly viewable.
Yes, the registrant is responsible for ensuring that the information provided in the registration record remains accurate and up-to-date.
Upon submission of the study for registration, the registry officer will then review the accomplished research form.

The study will either be rejected or approved. Rejected means there are other required information that the registrant needs to fill out.

Once all the required information are complete, the registry officer will approve the study. The registrant will be notified via email that the study has been registered.

The PHRR ID or Registry ID will be viewed when the registrant opens the title of the study using the registered account.
CLINICAL TRIAL
1. Public Title
2. Scientific Title
3. Registry ID
4. Secondary Identification Number
5. FDA Clinical Trial Reference Number
6. Project Description
7. Project Duration
8. Project Status
9. Implementing Agency (Primary Sponsor)
10. Cooperating Agency (Secondary Sponsor)
11. Funding Agency (Sources of Monetary or Material Support)
12. Contact for Public Queries (Name, Email, Phone Number, Postal Address)
13. Contact for Scientific Queries (Name, Email, Phone Number, Postal Address)
14. Investigating Team (Name, Expertise, Affiliation)
15. Project location and Institutional Ethics Review Board
16. Health Conditions or Problems Studied
17. Primary Outcomes
18. Key Secondary Outcomes
19. Recruitment Status
20. Countries of Recruitment
21. Research Classification
22. FDA Document Tracking Number
23. FDA/ERC Approval Date
24. Amendment Approval Date/Reasons
25. Key Inclusion and Exclusion Criteria
26. Study Type
27. Intervention Name
28. Intervention Description
29. Method of Allocation
30. Masking/Blinding
31. Masking Details
32. Assignment
33. Purpose
34. Phase
35. Target Sample Size (Philippines)
36. Actual Sample Size (Philippines)
37. Reason for Difference Between Target & Actual Sample Sizes
38. Date of First Enrollment
39. Research Utilization

NON-CLINICAL STUDIES
1. Public Title
2. Scientific Title
3. Registry ID
4. Project Description
5. NUHRA Details
6. Project Duration
7. Project Status
8. Implementing Agency (Primary Sponsor)
9. Cooperating Agency (Secondary Sponsor)
10. Funding Agency (Sources of Monetary or Material Support)
11. Contact for Public Queries (Name, Email, Phone Number, Postal Address)
12. Contact for Scientific Queries (Name, Email, Phone Number, Postal Address)
13. Investigating Team (Name, Expertise, Affiliation)
14. Primary Outcomes
15. Key Secondary Outcomes
16. Recruitment Status
17. Countries of Recruitment
18. Research Classification

Copyright © One Window Project 2020. All rights reserved.